News

Although controlled trial results of remdesivir for COVID-19 won't be available for several weeks, early experience with compassionate use is detailed in a new NEJM report.

Loss of smell or taste has been reported to occur with COVID-19 in absence of other symptoms, heightening risk of exposure for unknowing contacts.

Emergency room doctors in Wuhan tracked their own recoveries from coronavirus using a phone app to aid researchers.

Matthew Davis, PharmD, provides an overview on the agent remdesivir.

Organizational leaders can support their health care workers fighting COVID-19 in small ways. Start by asking “what do you need?”

Here is a look at infectious disease-related FDA news from the week of April 5, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Check out the latest coronavirus updates from Friday, April 10th.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The majority of critically ill patients admitted to the ICU in Lombardy, Italy with COVID-19 were older men and required mechanical ventilation.

Medical sleuths identify potential of baricitinib for COVID-19 by using artificial intelligence to sift through available agents that act on receptors of interest.

HIV training pathways in residency have added 90 HIV physicians to the workforce since 2006.

Thomas Dilworth, PharmD, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.

The system can be used among adult patients with COVID-19 who have been admitted to the ICU and are currently experiencing or will experience respiratory failure.

Check out the latest coronavirus updates from Thursday, April 9th.

When drug resistance means ART options are exhausted, HIV patients need newer choices. A new study shows that novel prodrug fostemsavir is an effective alternative.

Jason Kindrachuk, PhD, explains the animal reservoir spillover events involved in the emergence of viruses like SARS-CoV-2.

As governments and tech companies rush to find ways to use technology to track the spread of the novel coronavirus, a new paper cautions governments against going so quickly that they ignore privacy concerns.

The study authors followed up with 19 patients with pancreatic echinococcosis after their surgeries, as well as collected their treatment journeys.

The trial will evaluate the safety and effectiveness of the agent in adults who are hospitalized with the novel virus

Krutika N. Mediwala, PharmD, BCPS, BCIDP, provides a recap of available information regarding Kaletra for the treatment of COVID-19.

Stay up to date on the latest COVID-19 news for April 8, 2020.

Robert Salata, MD, discusses the ARMS-I clinical trial that will enroll clinical staff caring for patients with COVID-19.

Jason Kindrachuk, PhD, addresses clinician questions about SARS-CoV-2 such as the length of infectious viral shedding and whether the virus will become endemic.

While school closures reduce case transmission of COVID-19, they may also reduce the capacity of a strained health care labor force.

Anthony Fauci, MD, of NIAID, Robert Redfield, MD, of CDC, and others considered initial epidemiology from Wuhan China, and the need to obtain, and act on new data.

AEI’s report outlines needed steps for country to return to health—and business.

Wendy M. Bamberg, MD, the editor of Contagion®’s Emerging and Re-emerging Infections section, shares her thoughts on social distancing, managing suspect cases, and lessons we can learn about COVID-19.